Home > Signaling Pathways>Metabolic Enzyme/Protease>Proteasome>Marizomib (Salinosporamide A; NPI-0052)
Marizomib (Salinosporamide A; NPI-0052)

This product is for research use only, not for human use. We do not sell to patients.

Marizomib (Salinosporamide A; NPI-0052)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
100mg$12335To Be Confirmed
200mg$18500To Be Confirmed
500mg$27750To Be Confirmed

Cat #: V2138 CAS #: 437742-34-2 Purity ≥ 98%

Description: Marizomib (formerly also known as ML-858, NPI-0052 and Salinosporamide A), a naturally-occurring salinosporamide extracted from the marine actinomycete Salinospora tropica, is a potent and selective 20S proteasome inhibitor (IC50 = 1.3 nM) with potential antineoplastic activity.

References: Di K, et al. Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brainbarrier. Neuro Oncol. 2016 Jun;18(6):840-8.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)313.78
Molecular FormulaC15H20ClNO4
CAS No.437742-34-2
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
SMILES CodeC[C@]12[C@H](C(=O)N[C@]1(C(=O)O2)[C@H]([C@H]3CCCC=C3)O)CCCl
Synonyms(-)-Salinosporamide A; Salinosporamide A; ML 858; ML-858; ML858; NPI 0052; NPI-0052; NPI0052; Marizomib;
ProtocolIn VitroMarizomib (24 hours; 60 nM) induces apoptosis and caspase-3 activation in glioma cells. Marizomib (Salinosporamide A) (0.1-10000 nM; 72 hours) effectively reduces survival of D-54 and U-251 cells in a dose-dependent manner. The IC50s are ∼52 nM for U-251 and ∼20 nM for D-54.
In VivoMarizomib (Salinosporamide A) (0.15 mg/kg; i.v; twice a week for three weeks) significantly decreases tumor growth, and is not associated with any toxicity.
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM3.1869 mL15.9347 mL31.8695 mL63.7389 mL
5mM0.6374 mL3.1869 mL6.3739 mL12.7478 mL
10mM0.3187 mL1.5935 mL3.1869 mL6.3739 mL
20mM0.1593 mL0.7967 mL1.5935 mL3.1869 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.